Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies. It has several subsidiaries in North America and Europe including entities, such as Talem... see more

Bullboard (NDAQ:IPA)

View:
Post by theNormon Jan 17, 2021 6:22pm

Accumulation by Smart Money

When I look at 72 Credit Suise and 39 Merrill Lynch with high average purchase prices compared to CIBC the manipulator here, I feel assured I have picked a winner.    Can't predict when, ...more  
Post by theNormon Jan 17, 2021 6:20pm

Broker Summary

House Positions for C:IPA from 20201216 to 20210115 House Bought $Val Ave Sold $Val Ave Net $Net ...more  
Comment by wallpaper2on Jan 13, 2021 6:49am

RE:Door is wide open for a efficacious therapeutic

Tell us something we don't already know. The trials which were due to start in January and take 4 weeks to complete. Have they begun and if so when?  Several companies have already completed ...more  
Post by Hotspurs on Jan 11, 2021 11:09pm

Door is wide open for a efficacious therapeutic

https://theprovince.com/news/u-s-pharmaceutical-giant-lashes-out-b-c-ministry-of-health-after-drug-rejection/wcm/c77295f1-1a8f-4a82-93f2-6c72ce4df9f5/amp/#click=https://t.co/18EssT8Fe3
Post by theNormon Jan 11, 2021 7:54pm

New Investor Deck Jan 11

Same slides as jpm, stern ir, hc wainwright presentation -  NEW INVESTOR DECK JAN 11 https://www.immunoprecise.com/wp-content/uploads/2021/01/IPA_Investor_Deck_Janu2021.pdf
Comment by bingostaron Jan 06, 2021 8:54am

RE:RE:Cruising through after hours nicely

IPA is well postionned to tackle variants of the covid with its antibody cocktail, it will pay long term.
Comment by theNormon Jan 05, 2021 8:39pm

RE:Cruising through after hours nicely

Check out CEO.ca tonight.  Some real good discussion and dd, imo.  Here is the final after hrs tally Time ET Ex Price Change Volume  ...more  
Post by theNormon Jan 05, 2021 6:27pm

Cruising through after hours nicely

Recent Trades - Last 10 of 771 Time ET Ex Price Change Volume 17:56:01 Q 17.00 3.60 113  ...more  
Post by theNormon Jan 05, 2021 4:57am

JP Morgan Conference

https://sternir.com/JPM-2021 JP MORGAN is holding a virtual conference Jan 11-14 IPA is being promoted and we could see the shelf short form prospectus their holding brought into play. It allows for ...more  
Post by Right80%on Jan 04, 2021 10:10am

Very underwhelming

Clearly it got way ahead of itself. What's the floor $15 CAD? Nobody seems to care. 
Post by theNormon Jan 03, 2021 3:45am

Evening folks

Sentiment remains positive on CEO.ca and Yahoo   This will be one hellacious week to get through until the vote in the US Senate, as theDonald spreads fear in his last hours of power. The ...more  
Post by Rossaporinoon Jan 01, 2021 9:27pm

Happy new year Do your Own DD

https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
Post by theNormon Jan 01, 2021 6:21pm

Dec 30th news of New Consortium

IPA has vast amounts of expertise, patented IP and the most sought after antibodies and antigens They are becoming the dominate player in this space.  With this latest collaboration they have ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities